Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617
Latest Information Update: 06 Mar 2023
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary) ; Fludeoxyglucose F-18; Lutetium (177Lu) vipivotide tetraxetan
- Indications Adenoid cystic carcinoma
- Focus Diagnostic use
- 22 Mar 2021 New trial record
- 18 Mar 2021 Number of treatment arms is reduced from 2 to 1, by removing an Experimental: 68Ga-PSMA, PET/CT arm. Hence, the study becomes single-arm, and thus a randomized allocation is no longer required.